IP Verse

Adare competitive analysis

Latest oppositions filed by Adare

Explore patent oppositions filed by Adare against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026

Patent Number	Title	Applicant	Opposition Date
EP2886108	Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus	DR FALK PHARMA	Nov 6, 2019
EP2789250	An Aerosol Electronic Cigarette	FONTEM	Sep 26, 2019
EP3086782	Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus	DR FALK PHARMA	Jun 26, 2019

Latest patents of Adare opposed by its competitors

Explore Adare's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 16, 2026

Patent Number	Publication Date	Title	Total Oppositions
EP3041476	Jan 25, 2023	Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis	1
EP2646003	Jun 3, 2020	Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods	1
EP3403654	Jul 31, 2019	Orally Administered Corticosteroid Compositions	1
EP2482822	Aug 1, 2018	Orally Administered Corticosteroid Compositions	1

Latest PTAB cases involving Adare

Discover the latest PTAB cases involving Adare, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Adare with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ADARE I	-	3	-	-
DR FALK PHARMA	10	4	6	-